Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Section of Respiratory Medicine, Department of Translational Medicine, and.
Am J Respir Crit Care Med. 2023 May 1;207(9):1134-1144. doi: 10.1164/rccm.202209-1795CI.
Patients with chronic obstructive pulmonary disease (COPD) may suffer from acute episodes of worsening dyspnea, often associated with increased cough, sputum, and/or sputum purulence. These exacerbations of COPD (ECOPDs) impact health status, accelerate lung function decline, and increase the risk of hospitalization. Importantly, close to 20% of patients are readmitted within 30 days after hospital discharge, with great cost to the person and society. Approximately 25% and 65% of patients hospitalized for an ECOPD die within 1 and 5 years, respectively. Patients with COPD are usually older and frequently have concomitant chronic diseases, including heart failure, coronary artery disease, arrhythmias, interstitial lung diseases, bronchiectasis, asthma, anxiety, and depression, and are also at increased risk of developing pneumonia, pulmonary embolism, and pneumothorax. All of these morbidities not only increase the risk of subsequent ECOPDs but can also mimic or aggravate them. Importantly, close to 70% of readmissions after an ECOPD hospitalization result from decompensation of other morbidities. These observations suggest that in patients with COPD with worsening dyspnea but without the other classic characteristics of ECOPD, a careful search for these morbidities can help detect them and allow appropriate treatment. For most morbidities, a thorough clinical evaluation supplemented by appropriate clinical investigations can guide the healthcare provider to make a precise diagnosis. This perspective integrates the currently dispersed information available and provides a practical approach to patients with COPD complaining of worsening respiratory symptoms, particularly dyspnea. A systematic approach should help improve outcomes and the personal and societal cost of ECOPDs.
慢性阻塞性肺疾病(COPD)患者可能会经历呼吸困难恶化的急性发作,通常伴有咳嗽、咳痰和/或痰脓性增加。这些 COPD 加重(ECOPD)会影响健康状况,加速肺功能下降,并增加住院风险。重要的是,近 20%的患者在出院后 30 天内再次入院,给个人和社会带来巨大的经济负担。大约 25%和 65%的 ECOPD 住院患者分别在 1 年和 5 年内死亡。COPD 患者通常年龄较大,并且经常伴有其他慢性疾病,包括心力衰竭、冠状动脉疾病、心律失常、间质性肺疾病、支气管扩张、哮喘、焦虑和抑郁,并且发生肺炎、肺栓塞和气胸的风险也增加。所有这些疾病不仅增加了随后发生 ECOPD 的风险,而且还可能模拟或加重 ECOPD。重要的是,ECOPD 住院后近 70%的再次入院是由于其他疾病的恶化。这些观察结果表明,对于出现呼吸困难恶化但没有 ECOPD 其他典型特征的 COPD 患者,仔细寻找这些疾病可以帮助发现这些疾病并进行适当的治疗。对于大多数疾病,全面的临床评估辅以适当的临床检查可以帮助医疗保健提供者做出准确的诊断。这种观点整合了目前分散的可用信息,并为出现呼吸症状恶化(尤其是呼吸困难)的 COPD 患者提供了一种实用的方法。系统的方法应该有助于改善结果,并降低 ECOPD 的个人和社会成本。